JC110 (O&G) - Medical disorders in Pregnancy Flashcards
List chronic medical conditions that must be optimized before pregnancy
Pre-existing hypertension Diabetes Autoimmune diseases Renal disease Cardiac diseases Asthma
List medical conditions that is caused by pregnancy
Hyperemesis gravidarum Gestational hypertension Gestational diabetes Acute fatty liver of pregnancy Acute renal failure DIC secondary to obstetrics complications (e.g. postpartum hemorrhage)
List medical conditions aggravated by pregnancy
Iron deficiency anaemia
Thromboembolism
Management of maternal health before pregnancy
Optimize her medical disorder
Substitute teratogenic medications if possible
Advise on whether she is medically fit to get pregnant
Contraceptive advice if needed
Management of maternal health during pregnancy
Assess whether medically fit to continue pregnancy
Monitor her and her fetus throughout the pregnancy
Detect fetal congenital abnormalities/ growth problem with ultrasound
Monitor and control her medical disorder
Management of maternal health during delivery
Plan/ decide on the timing and mode of delivery ahead of time
Consider early delivery if her medical disorder is uncontrolled/ complications arise
Make an individualized intrapartum and postpartum management plan when necessary
In labor, monitor her medical disorder, fetal well-being and progress of labor
Management of maternal health after delivary
Assess her baby by a paediatrician
Encourage breastfeeding, except where lactation is contraindicated for certain maternal drugs
Optimize medical disorders and medications
Discuss contraception:
May need to avoid another pregnancy shortly or in the long term
Some medical disorders may affect her eligibility to some contraceptive methods
4 types of hypertension during pregnancy
Pre-existing:
- Hypertension: high BP before 20 weeks
- Renal disease: proteinuria before 20 weeks
Gestational: high BP first detected after 20 weeks
Without proteinuria = Gestational HT
With proteinuria = pre- eclampsia (hypertension + proteinuria + oedema)
Pre-existing hypertension with superimposed pre-eclampsia
Unclassified: No antenatal care before (unknown whether HT occurred before 20 weeks)
Management of maternal hypertension in pregnancy
- Purpose of optimizing control
- Investigations
- Drugs
Purpose:
- Optimize drugs to prevent intracerebral hemorrhage or uterine hypoperfusion/ fetal hypoxia
- Prevent eclampsia
Ix: (screen and manage associated complication: HELLP, coagulopathy, renal failure)
Complete blood picture
Renal/liver function tests
Coagulation tests’
Drugs:
- Most antihypertensive except ACEi and Propranolol
- IV labetalol
- Pre-eclampsia: Vasodilators - hydralazine
- Eclampsia: Magnesium sulphate (antiepileptic)
Describe the effects of pregnancy on blood glucose control and DM
Pregnancy alters carbohydrate metabolism, more difficult to control blood glucose:
- Insulin resistance increases with gestation period:
- Placental hormones antagonize insulin (e.g. cortisol, oestrogens, progesterone, human placental lactogen)
- Placenta degrades insulin - Increase stress and end-organ damage on cardiovascular and renal system, increase diabetic retinopathy
- Increase metabolic demand: Fasting hypoglycaemia
Complications of DM on mother during pregnancy
Increase risk of:
- Pre-eclampsia
- UTI
- Pre-term labor
Increase incidence of C-section and instrumental delivery
Complications of maternal DM on fetus
Antenatal
- Increase risk of congenital malformations: E.g. neural tube, skeletal, cardiac, renal, gastrointestinal
- Polyhydramnios
- Spontaneous miscarriage, stillbirth, Preterm delivery
- Large-for-gestational age/ macrosomia
Neonatal:
- Asphyxia, birth trauma
- Jaundice, needing phototherapy
- Metabolic, respiratory distress syndrome
- Sepsis
- Fetal programming effect on metabolic and cardiovascular diseases
Management of maternal DM before pregnancy
Pre-pregnancy counseling:
-
Better glycaemic control (need home blood glucose monitoring, optimize drugs)
- Hyperglycaemia is teratogenic
- Incidence of major congenital abnormality correlates with HbA1c level - Avoid OC pills (risk of stroke), may use IUCD
Management of maternal DM during pregnancy
DM, Diet, Obstetrics management
DM control:
- Strict glycaemic control with oral hypoglycaemic agents
- Insulin dosage adjustment in type 1 DM
- Hotline for glycaemic control with regular follow-up
Diet:
- Increase caloric intake for baby’s demand
Obstetrics:
- Fetal ultrasound for fetal growth, exclude congenital abnormalities
- Monitor maternal and fetal complications
- Intra-partum: tight glucose control with Insulin-dextrose drip and potassium replacement (prevent RDS, fetal hypoglycemia)
Post-partum management of fetus born from mother with DM
Neonatal assessment
Regular blood glucose monitoring by dextrostix (e.g. hypoglycaemia)
Neonatal jaundice and phototherapy
Thyroid diseases associated with pregnancy
Maternal Grave’s disease causing neonatal thyrotoxicosis
Transient biochemical hyperthyroidism in mother, a/w hyperemesis gravidarum
Subclinical hypothyroidism (High TSH, Normal fT4) in mother - Causes preterm labor, delayed neurological development in offsprings
Treatment of hyperthyroidism and hypothyroidism during pregnancy
Hyperthyroidism:
- Radioactive iodine contraindicated in pregnancy***
- Propylthiouracil (PTU) and carbimazole are commonly used: no teratogenicity
- Risk: PTU liver failure, transient neonatal hypothyroidism
Hypothyroidism:
- Thyroxine replacement
Autoimmune diseases associated with pregnancy
Maternal diseases and effects on fetus
Autoantibodies crossing placenta:
- idiopathic thrombocytopenia purpura/ ITP»_space; fetal thrombocytopenia and excessive bleeding during delivery
- Anti-Ro antibodies»_space; Congenital heart block
- SLE»_space; Neonatal lupus
- Lupus anticoagulant, anticardiolipin»_space; IUGR, pregnancy loss
End organ damage:
- Autoimmune thyroiditis»_space; Delayed fetal neurological development
- Autoimmune renal disease»_space; IUGR, superimposed pre-eclampsia
Describe the effect of pregnancy on maternal autoimmune diseases
- Pregnancy modulates immune system: alleviate or worsen autoimmune diseases
- Pregnancy increases metabolic demand and stress on end-organs: exacerbate end-organ damage by autoimmune diseases
- Pregnancy is contraindicated during acute flare of autoimmune diseases
Describe the effect of autoimmune disease treatment on fetus
Steroids: IUGR, Cleft lip
Immunosuppressants: Teratogenic (azathioprine is safe)
Cytotoxic drugs: Teratogenic, pregnancy loss
Describe the effects of pregnancy on maternal cardiac conditions
Explain why pregnancy exacerbates cardiac conditions
Heart failure during pregnancy due to:
- Increase cardiac output for fetus
- Antenatal anemia
- Drug-use in pregnancy (β-adrenergics for arresting preterm labour)
Delivery:
- Stress and physical demand during labour and delivery
- Excessive intravenous fluids during labor (congestive HF)
Postpartum Volume overload due to resorption of uterine blood into systemic circulation
- Right heart failure
- Increase R to L shunt with pulmonary hypertension
Describe effects of maternal cardiac conditions on fetus
Effects on fetus:
- Smaller fetal size (IUGR)
- More frequent preterm labour
Reasons:
Cardiac condition may limit the normal physiological increase in the cardiac output
Hypoxia in cyanotic heart disease affects growth of fetus
Cardiac drugs contraindicated during pregnancy
Diuretics (e.g. frusemide) - limits physiological volume expansion, IUGR
Warfarin:
- Warfarin embryopathy in 1st trimester
- Intracranial hemorrhage and fetal loss in 2nd trimester
ACEi:
- Fetal loss, oligohydramnios, fetal renal hypoperfusion
Propranolol
Management of cardiac conditions during pregnancy
General:
- Regular assessment by cardiologist - every 4 weeks till 32 weeks then every 2 weeks
- Monitor fetal growth every 4 weeks
- Induce labor +/- C-section if necessary
Drugs:
- Stop and substitute all teratogenic drugs before 1st trimester
- Adjust Digoxin dosage
Surgical:
- Postpone cardiac catheterization, open-heart surgery and valve replacements
Heart valve diseases:
- Antibiotic prophylaxis against bacterial IE during delivery
- Prevent thromboembolism
Management of epilepsy during pregnancy
Continue control of epilepsy despite teratogenic potential (e.g. cleft lip, cleft palate, neural tube defects)
- Keep antiepileptic drugs
- Switch to monotherapy if possible
- Increase folic acid supplement dose (protect against neural defect)
- Prenatal US exam for fetal morphology
Describe the effects of pregnancy on venous thromboembolism
Pregnancy increases Virchow’s triad/ risk factors for thromboembolism
1. Immobility : relatively less mobile during pregnancy, bed rest
- Hypercoagulability: aggravated by pre-clampsia and hyperemesis
- Obstruction to blood flow: Gravid uterus
Risk factors of venous thromboembolism during pregnancy
Pre-existing risks:
Demographic (advanced age, obesity, ethnicity (Caucasian))
Smoking
Congenital/ acquired thrombophilia
Family history/ past history of thromboembolism
Pregnancy:
- Pre-eclampsia and hyperemesis (increase blood viscosity)
- Long bed rests, injuries causing immobilization
- C-section delivery
- Post-partum genital infection
Prevention of venous thromboembolism during pregnancy
- Minimize immobility: especially for threatened miscarriage, IUGR
- Adequate hydration
- High risk of thromboembolism:
- Compression stocking
- Prophylactic anticoagulants:
LMWH/ heparin for antenatal and short-term post-natal.
Warfarin for post-natal ONLY.
Regimens of prophylactic anticoagulation for pregnant women at risk of thromboembolism
High risk:
- continue anticoagulant for 10 days after Caesarean section in pt with preeclampsia
- continue during immobilization
very high risk (e.g. previous DVT)
- Cover 6 weeks postpartum
very very high risk (e.g. antiphospholipid syndrome, previous pulmonary embolism)
- Cover throughout pregnancy + 6 weeks postpartum
Prophylaxis with heparin/ LMWH, only use warfain post-partum
Warfarin is safe for use during pregnancy
True or False?
Warfarin (oral):
Crosses placenta, teratogenic (warfarin embryopathy) - avoided in 1st (and 2nd) trimester
Long half-life - avoided in 3rd trimester (after 36 weeks) to prepare for delivery (should use heparin instead)
Only safe for breastfeeding, post-partum use
Liver disease associated with pregnancy
Deranged liver function (HELLP in pre-eclampsia)
Acute fatty liver of pregnancy
Cholestasis of pregnancy
reactivation of hepatitis B due to altered immunity and increase stress post-partum